A preliminary cost-utility analysis of routine myasthenia gravis and thyroid dysfunction screening in acquired comitant Esotropia. [PDF]
Srimanan W +2 more
europepmc +1 more source
Untargeted serum metabolomic profiling in patients with generalized and ocular myasthenia gravis. [PDF]
Wei B, Yuan H, He J, Hu Y, Li J, Wu X.
europepmc +1 more source
Real-world experience with efgartigimod in generalized myasthenia gravis: a single-center retrospective study in China. [PDF]
Niu Z +9 more
europepmc +1 more source
Navigating Anxiety Management in Myasthenia Gravis Crisis With Prolonged Corrected QT (QTc): A Case Report. [PDF]
Burky G.
europepmc +1 more source
Low-dose versus standard-dose intravenous immunoglobulin in generalized myasthenia gravis: a prospective single-center cohort study. [PDF]
Luo H +9 more
europepmc +1 more source
Efgartigimod in Patients with Generalized Myasthenia Gravis Refractory or Intolerant to IVIg. [PDF]
D'Amico F +10 more
europepmc +1 more source
Digital Monitoring of Patients with Generalized Myasthenia Gravis: A Prospective Pilot Study. [PDF]
Vesperinas A +10 more
europepmc +1 more source
Evaluation of steroid toxicity using the Glucocorticoid Toxicity Index-Metabolic Domains instrument in adults with myasthenia gravis: a real-world study in the USA. [PDF]
Phillips G +8 more
europepmc +1 more source

